Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.

Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI, Kazakos KA, Yovos JG, Zebekakis PE, Tziolas IM, Tourkantonis AN.

J Hypertens. 2004 Sep;22(9):1769-77.

PMID:
15311106
2.

Effects of the thiazolidinediones on cardiovascular risk factors.

Gilling L, Suwattee P, DeSouza C, Asnani S, Fonseca V.

Am J Cardiovasc Drugs. 2002;2(3):149-56. Review.

PMID:
14727977
3.

[Seasonal variations of blood pressure in normal subjects and patients with chronic disease].

Verdon F, Jacot E, Boudry JF, Chuat M, Truong CB, Studer JP.

Arch Mal Coeur Vaiss. 1997 Sep;90(9):1239-46. Review. French.

PMID:
9488770
4.

Endothelial dysfunction and hypertension in diabetes mellitus.

Dandona P, Chaudhuri A, Aljada A.

Med Clin North Am. 2004 Jul;88(4):911-31, x-xi. Review.

PMID:
15308385
5.

Nighttime blood pressure: a target for therapy?

Waeber B, Mourad JJ, O'Brien E.

Curr Hypertens Rep. 2010 Dec;12(6):474-9. doi: 10.1007/s11906-010-0152-0. Review.

PMID:
20862569
6.

Rosiglitazone reduces blood pressure and urinary albumin excretion in type 2 diabetes: G Bakris et al.

Grossman E.

J Hum Hypertens. 2003 Jan;17(1):5-6. Review. No abstract available.

PMID:
12571610
7.

Insulin resistance in systemic hypertension: pharmacotherapeutic implications.

Mediratta S, Fozailoff A, Frishman WH.

J Clin Pharmacol. 1995 Oct;35(10):943-56. Review.

PMID:
8568012
8.

[Pioglitazone effects on blood pressure in patients with metabolic syndrome].

Takahashi A, Kushiro T.

Nihon Rinsho. 2008 Aug;66(8):1591-5. Review. Japanese.

PMID:
18700562
9.

Methods for evaluating the duration of action of once-daily antihypertensive therapy.

Myers MG.

Blood Press Monit. 2003 Aug;8(4):161-3. Review.

PMID:
14517479
11.

Pediatric hypertension 2001.

Rocchini AP.

Curr Opin Cardiol. 2002 Jul;17(4):385-9. Review.

PMID:
12151874
12.

Trough to peak ratio as a guide to BP control: measurement and calculation.

Morgan T, Ménard J, Brunner H.

J Hum Hypertens. 1998 Jan;12(1):49-53. Review. No abstract available.

PMID:
9482134
13.

[Treatment of hypertension with device-guided breathing exercise].

Grossman A, Grossman E.

Harefuah. 2003 Oct;142(10):677-9, 718. Review. Hebrew.

PMID:
14565066
14.

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.

Baker WL, Buckley LF, Kelly MS, Bucheit JD, Parod ED, Brown R, Carbone S, Abbate A, Dixon DL.

J Am Heart Assoc. 2017 May 18;6(5). pii: e005686. doi: 10.1161/JAHA.117.005686. Review.

15.

Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.

Rabi DM, Padwal R, Tobe SW, Gilbert RE, Leiter LA, Quinn RR, Khan N; Canadian Hypertensive Education Program; Canadian Diabetes Association.

CMAJ. 2013 Aug 6;185(11):963-7. doi: 10.1503/cmaj.120112. Epub 2013 Jun 3. Review. No abstract available.

16.

[Insulin sensitivity, blood pressure and cardiovascular diseases].

Marre M, Collet C, Moisan C, Stevenin C, Larger E.

Diabetes Metab. 2001 Apr;27(2 Pt 2):229-32. Review. French.

PMID:
11452215
17.

Safety of blood donation from individuals with treated hypertension or non-insulin dependent type 2 diabetes - a systematic review.

Stainsby D, Brunskill S, Chapman CE, Dorée C, Stanworth S.

Vox Sang. 2010 Apr;98(3 Pt 2):431-40. doi: 10.1111/j.1423-0410.2009.01275.x. Epub 2009 Oct 29. Review.

PMID:
19878496

Supplemental Content

Support Center